PopVax Announces 1.15 Million USD in Funding from the Bill and Melinda Gates Foundation for Thermostable mRNA Delivery Formulation Development
BusinessWire India Mumbai Maharashtra Hyderabad Telangana [India] October 30 PopVax an Indian full-stack biotechnology ...
Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments
Lexaria's strategy is to continue developing and optimizing our wholly-owned DehydraTECH™ drug delivery platform for application in the GLP-1 space, positioning it as a 'must-have' technology for ...
Nasdaq13d
Top 4 Canadian Biotech Stocks of 2024
Trials for the candidate are advancing. On July 8, the company entered into a collaborative agreement with NanoVation Therapeutics, a biotech company that develops customized nucleic acid and ...
Yahoo Finance11d
PopVax Announces 1.15 Million USD in Funding from the Bill & Melinda Gates Foundation for Thermostable mRNA Delivery Formulation Development
who previously worked with pioneering nucleic acid delivery research groups at NanoVation Therapeutics and during his PhD at the University of British Columbia in Canada. "We at PopVax are ...
PMLiVE19d
Novo Nordisk’s Alhemo recommended by CHMP for haemophilia A and B
The recommendation comes just one month after Novo entered into a multi-year partnership with NanoVation Therapeutics to advance genetic medicines for cardiometabolic and rare diseases. The deal, ...